Karyopharm Therapeutics (KPTI) Net Margin Growth (3y) (2015 - 2026)
Karyopharm Therapeutics (KPTI) Net Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -389.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -13,815.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7,793.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 9,934.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -11,156.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,387.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -5,319.00 |
| 10 | Karyopharm Therapeutics | 56.72 Mn | 56.72 Mn | 32.35 Mn | -11,365.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11,365.00 |
| Dec 31, 2025 | 50,295.00 |
| Sep 30, 2025 | 2,528.00 |
| Jun 30, 2025 | 2,543.00 |
| Mar 31, 2025 | 868.00 |
| Dec 31, 2024 | 11,885.00 |
| Sep 30, 2024 | 5,478.00 |
| Jun 30, 2024 | 29,268.00 |
| Mar 31, 2024 | 13,405.00 |
| Dec 31, 2023 | -2,909.00 |
| Sep 30, 2023 | 15,494.00 |
| Jun 30, 2023 | 5,170.00 |
| Mar 31, 2023 | 20,364.00 |
| Dec 31, 2022 | 15,141.00 |
| Sep 30, 2022 | 21,411.00 |
| Jun 30, 2022 | 33,369.00 |
| Mar 31, 2022 | 4.26 Mn |
| Dec 31, 2021 | 2.83 Mn |
| Sep 30, 2021 | 2.00 Mn |
| Jun 30, 2021 | -6,788.00 |